SEC 13F Intelligence

Boxer Capital, LLC / IMMU

Boxer Capital, LLC’s Immunomedics Inc Position

Does Boxer Capital, LLC own Immunomedics Inc (IMMU)? Not currently — the last reported position was 4.50M shares worth $383M in Q3 2020; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$383M
Q3 2020
Shares
4.50M
% of Portfolio
+13.22%
Quarters Held
8
position exited

Position History IMMU

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’19: $79MQ1 ’19Q2 ’19: $91MQ2 ’19Q3 ’19: $92MQ3 ’19Q4 ’19: $179MQ4 ’19Q1 ’20: $114MQ1 ’20Q2 ’20: $234MQ2 ’20Q3 ’20: $383MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20204.50M$383M+13.22%
Q2 20206.61M$234M+10.29%
Q1 20208.45M$114M+7.76%
Q4 20198.45M$179M+10.11%
Q3 20196.95M$92M+6.68%
Q2 20196.57M$91M+7.83%
Q1 20194.10M$79M+9.11%
Q4 20181.15M$16M+2.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of IMMU.